Acarbose NDC 63629-5698

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-5698Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-5698Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63629-5698-1	63629569801	30 TABLET in 1 BOTTLE (63629-5698-1)Marketed from Dec 10, 2016
63629-5698-2	63629569802	90 TABLET in 1 BOTTLE (63629-5698-2)Marketed from Dec 10, 2016
63629-5698-3	63629569803	100 TABLET in 1 BOTTLE (63629-5698-3)Marketed from Dec 10, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acarbose
Generic name (nonproprietary): acarbose
Active ingredients: Acarbose — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090912
Marketing start: Dec 10, 2016
Listing expires: Dec 31, 2027
Other FDA classes: alpha Glucosidase Inhibitors (Mechanism)
Identifiers: Product ID 63629-5698_539553ec-baa9-4e89-ae74-81515af2c7b8SPL ID 539553ec-baa9-4e89-ae74-81515af2c7b8SPL set ID 1ba7a072-03b0-41f2-be7a-101145bdef3aRxCUI 199149, 200132UNII T58MSI464G
Pharmacologic class: alpha-Glucosidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629569801 followed by a unit qualifier and the quantity

Package 63629-5698-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 11, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Acarbose Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090912

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090912
Product	Strength	Form · route	Labeler	Product NDC
Acarbose	Acarbose 50 mg/1	TabletOral	Strides Pharma Science Limited	64380-759
Acarbose	Acarbose 25 mg/1	TabletOral	Strides Pharma Science Limited	64380-758
Acarbose	Acarbose 100 mg/1	TabletOral	Strides Pharma Science Limited	64380-760